Series B - Halo Labs

Series B - Halo Labs

Investment Firm

Overview

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

Announced Date

Apr 06, 2020

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Research Corporation Technologies

Research Corporation Technologies

Research Corporation Technologies is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

4

Investor Name
Participant InvestorPaul McEwan
Participant InvestorResearch Corporation Technologies
Participant InvestorBroadOak Capital Partners
Participant InvestorBioAdvance

Round Details and Background

Halo Labs raised $12000000 on 2020-04-06 in Series B

Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.

Company Funding History

10

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 08, 2013
Seed Round - Halo Labs
1-undefined
Jun 26, 2012
Seed Round - Halo Labs
1-750.0K
Jan 30, 2014
Non Equity Assistance - Halo Labs
1-50.0K
May 06, 2015
Seed Round - Halo Labs
1-75.0K

Recent Activity

There is no recent news or activity for this profile.